Tumor-associated Stromal Cells Expressing E-prostanoid 2 or 3 Receptors in Prostate Cancer: Correlation With Tumor Aggressiveness and Outcome by Angiogenesis and Lymphangiogenesis

被引:13
作者
Miyata, Yasuyoshi
Ohba, Kojiro
Matsuo, Tomohiro
Watanabe, Shin-Ichi
Hayashi, Tomayoshi
Sakai, Hideki
Kanetake, Hiroshi
机构
[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Nephrourol, Nagasaki 8528501, Japan
[2] Nagasaki Univ Hosp, Dept Pathol, Nagasaki, Japan
基金
日本学术振兴会;
关键词
ENDOTHELIAL GROWTH-FACTOR; POSSIBLE AUTOCRINE/PARACRINE REGULATION; PROSTAGLANDIN E-2; CYCLOOXYGENASE-2; EXPRESSION; MACROPHAGES; ADENOCARCINOMA; DEGRANULATION; ACTIVATION; MECHANISMS; CARCINOMA;
D O I
10.1016/j.urology.2012.08.014
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To clarify the detailed pathologic roles of prostaglandin E-2 in prostate cancer tissues, the present study investigated the clinical significance and prognostic roles of the density of tumor-associated stromal cells expressing specific receptors for prostaglandin E-2, termed "E-prostanoid (EP)1-4 receptors (EP1R-4Rs)." METHODS The expression of each receptor was immunohistochemically examined in 114 formalin-fixed biopsy specimens. Correlations with clinicopathologic features were investigated in these specimens. Angiogenesis and lymphangiogenesis were measured by the percentage of CD34-stained vessels (microvessel density) and D2-40-stained vessels (lymph vessel density). The relationships between the density of each EPR-stained cells and the microvessel density or lymph vessel density were evaluated in 62 prostate cancer tissues obtained by radical surgery for more detailed analysis in a wider area of prostate cancer tissue. RESULTS The density of tumor-associated cells with EP2R expression was positively associated with the N (P < .001) and M ( P = .002) stages. Similarly, EP3R-positive stromal cell density was significantly associated with the N (P = .033) and M (P = .026) stages. The density of EP2R- and EP3R-stained cells correlated with the microvessel density (r = 0.42, P < .001) and lymph vessel density (r = 0.36, P = .012), respectively. A greater density of EP2R-stained cells was recognized as an independent predictor of progression (hazard ratio 7.26, P = .002) on multivariate analysis. CONCLUSION EP2R- and EP3R-stained cells might play important roles in tumor progression, angiogenesis, and lymphangiogenesis in prostate cancer. The density of EP2R-stained stromal cells could offer a useful predictor of biochemical recurrence after radical surgery. UROLOGY 81: 136-142, 2013. (c) 2013 Elsevier Inc.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 29 条
  • [11] Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: Association with vascular endothelial growth factors a to D immunohistochemistry
    Iwata, Takahisa
    Miyata, Yasuyoshi
    Kanda, Shigeru
    Nishikido, Masaharu
    Hayashi, Tornayoshi
    Sakai, Hideki
    Kanetake, Hiroshi
    [J]. UROLOGY, 2008, 71 (04) : 749 - 754
  • [12] Jabbour HN, 2001, BRIT J CANCER, V85, P1023
  • [13] Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression
    Kataki, A
    Scheid, P
    Piet, M
    Marie, B
    Martinet, N
    Martinet, Y
    Vignaud, JM
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2002, 140 (05): : 320 - 328
  • [14] Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development
    Kawamori, T
    Uchiya, N
    Nakatsugi, S
    Watanabe, K
    Ohuchida, S
    Yamamoto, H
    Maruyama, T
    Kondo, K
    Sugimura, T
    Wakabayashi, K
    [J]. CARCINOGENESIS, 2001, 22 (12) : 2001 - 2004
  • [15] Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis
    Kubo, Hidefumi
    Hosono, Kanako
    Suzuki, Tatsunori
    Ogawa, Yasufumi
    Kato, Hiroshi
    Kamata, Hiroki
    Ito, Yoshiya
    Amano, Hideki
    Kato, Tetsuki
    Sakagami, Hiroyuki
    Hayashi, Izumi
    Sugimoto, Yukihiko
    Narumiya, Shuh
    Watanabe, Masahiko
    Majima, Masataka
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (02) : 101 - 106
  • [16] Relationship between prostaglandin E2 receptors and clinicopathologic features in human prostate cancer tissue
    Miyata, Yasuyoshi
    Kanda, Shigeru
    Maruta, Sugure
    Matsuo, Tomohiro
    Sakai, Hideki
    Hayashi, Tomayoshi
    Kanetake, Hiroshi
    [J]. UROLOGY, 2006, 68 (06) : 1360 - 1365
  • [17] Prostaglandin E2 Stimulates the Production of Vascular Endothelial Growth Factor through the E-Prostanoid-2 Receptor in Cultured Human Lung Fibroblasts
    Nakanishi, Masanori
    Sato, Tadashi
    Li, Yingji
    Nelson, Amy J.
    Farid, Maha
    Michalski, Joel
    Kanaji, Nobuhiro
    Wang, Xingqi
    Basma, Hesham
    Patil, Amol
    Goraya, Jadvinder
    Liu, Xiangde
    Togo, Shinsaku
    Toews, Myron L.
    Holz, Olaf
    Muller, Kai-Christian
    Magnussen, Helgo
    Rennard, Stephen I.
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2012, 46 (02) : 217 - 223
  • [18] Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse
    Nataraj, C
    Thomas, DW
    Tilley, SL
    Nguyen, M
    Mannon, R
    Koller, BH
    Coffman, TM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (08) : 1229 - 1235
  • [19] Receptors and signaling mechanisms required for prostaglandin E2-mediated regulation of mast cell degranulation and IL-6 production
    Nguyen, MT
    Solle, M
    Audoly, LP
    Tilley, SL
    Stock, JL
    McNeish, JD
    Coffman, TM
    Dombrowicz, D
    Koller, BH
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (08) : 4586 - 4593
  • [20] Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion
    Nithipatikom, K
    Isbell, MA
    Lindholm, PF
    Kajdacsy-Balla, A
    Kaul, S
    Campell, WB
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (07) : 593 - 601